Keytruda

Keytruda is a medication used to treat various types of cancer, including melanoma, lung cancer, and certain blood cancers. It works by helping the immune system recognize and attack cancer cells more effectively. The medication is given as an intravenous infusion, typically at a starting dose of 200 mg every three weeks, or 400 mg every six weeks, depending on the specific condition being treated. It's important to know that Keytruda can cause serious immune-related side effects, so patients should be monitored closely for any unusual symptoms. Additionally, patients with autoimmune diseases or those requiring immunosuppressive medications should avoid using Keytruda, as it may worsen their condition.